CRMD - CIK 0001410098
The table below shows CorMedix Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $175.05M | -$50.62M | -$38.41M | -$24.36M | -$21.16M | -$21.97M |
| Capital expenditure | $2.26M | $116.00K | $327.30K | $219.36K | $1.43M | $112.64K |
| Investing cash flow | -$308.43M | $21.23M | -$17.06M | -$3.71M | -$9.13M | $7.43M |
| Dividends paid | - | - | - | - | - |
CorMedix Inc. reported operating cash flow of $175.05M for fiscal year 2025. That is up 445.8% from -$50.62M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$22.27M (FY 2016) to $175.05M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $238.45M | $26.32M | $55.92M | $17.90M | $41.76M | $40.10M |